North America Diabetes Care Devices Market Regional Share, Global Size, Trends, Segmentation and Forecast to 2028


 The North America diabetes care devices market is expected to grow from US$ 11,149.93 million in 2022 to US$ 16,386.63 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Diabetes among the geriatric population is a growing public health burden. It is a major cause of morbidity and mortality in the aging population and leads to various chronic complications. Moreover, this population is growing exponentially. As per a UN report (2019), in 2019, there were 200.4 million people aged 65 and older in North America. Moreover, according to a report by the UN (2019), the regional geriatric population is expected to double over the next three decades. The geriatric population is more likely to have diabetes than the younger population, and its effect on the quality of life is particularly more in the former population. With a rise in the geriatric population, the prevalence of diabetes has increased. Therefore, there is an increase in demand for diabetes care devices, which is driving the market. With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America diabetes care devices market. The North America diabetes care devices market is expected to grow at a good CAGR during the forecast period.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00005738

North America Diabetes Care Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Diabetes Care Devices Market Segmentation

 The North America diabetes care devices market is segmented based on type, end user, and country. Based on type, the North America diabetes care devices market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further categorized into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others. In terms of end user, the North America diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the North America diabetes care devices market has been categorized into the US, Canada, and Mexico. The US would dominate the market in 2022. B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the North America diabetes care devices market.

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-diabetes-care-devices-market

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

B. Braun Melsungen AG

BD

Dexcom, Inc.

Eli Lilly and Company.

F. Hoffmann-La Roche Ltd.

Insulet Corporation

Medtronic

Novo Nordisk A/S

Tandem Diabetes Care Inc.

Terumo Corporation

North America Diabetes Care Devices Market

The North American diabetes care devices market is experiencing significant growth due to the increasing prevalence of diabetes, rising awareness of the importance of managing the disease, and advancements in medical technology. This market includes various devices such as glucose monitors, insulin pumps, diabetes management software, and other tools designed to aid individuals in controlling their blood sugar levels and overall health. North America, which includes the United States, Canada, and Mexico, is home to a large number of individuals living with diabetes, thus driving the demand for more innovative and effective diabetes care devices. This market is projected to continue growing over the coming years due to factors such as technological advancements, a rise in the geriatric population, and increasing healthcare investments.

Market Overview

Diabetes is one of the most prevalent chronic diseases in North America, affecting millions of people across the region. In 2020, the International Diabetes Federation (IDF) estimated that more than 30 million Americans were living with diabetes, with Canada also reporting a significant number of affected individuals. This high prevalence rate is a major driver of the demand for diabetes care devices.

The market for diabetes care devices in North America encompasses several different categories of products, including glucose monitoring devices, insulin delivery devices, and other tools designed to support diabetes management. These devices help patients monitor their blood glucose levels, inject insulin when necessary, and track their overall health in real time. The increasing adoption of these devices is improving the quality of life for many individuals living with diabetes.

Key Drivers of Growth

  1. Rising Prevalence of Diabetes: The prevalence of diabetes in North America has been steadily rising over the past few decades. The increasing incidence of type 2 diabetes, in particular, is a major contributor to this trend. This rise in diabetes cases is partly due to factors such as poor lifestyle choices, unhealthy diets, physical inactivity, and genetic predisposition. As the number of diabetes patients increases, so does the demand for effective management solutions in the form of diabetes care devices.
  2. Technological Advancements: One of the main factors driving the growth of the North American diabetes care devices market is the ongoing technological advancements in medical devices. Continuous glucose monitoring (CGM) systems, insulin pumps, smart insulin pens, and other devices have revolutionized diabetes care by making it easier for individuals to track their blood glucose levels in real time. These advancements allow for more personalized care and better control over blood sugar levels, which is essential in managing both type 1 and type 2 diabetes. As technology continues to evolve, the market is expected to witness the development of even more efficient and user-friendly diabetes care devices.
  3. Government and Healthcare Support: Both the U.S. and Canadian governments, as well as private healthcare organizations, are increasingly focused on addressing the diabetes epidemic. In the U.S., Medicare and Medicaid programs provide coverage for many diabetes care devices, helping patients access the tools they need to manage their condition. Similarly, in Canada, healthcare plans often include coverage for diabetes care supplies. This accessibility to diabetes care devices is making it easier for patients to adopt and regularly use these tools, further fueling market growth.
  4. Growing Awareness and Education: There has been a significant increase in public awareness and education about diabetes in North America. Health organizations, government bodies, and advocacy groups have launched various campaigns to raise awareness of diabetes risk factors and the importance of early detection and proper management. This increased awareness has encouraged more individuals to monitor their health regularly and use diabetes care devices, which, in turn, has driven demand for these products.
  5. Aging Population: As the population in North America continues to age, the number of individuals at risk of developing type 2 diabetes is growing. Older adults are more likely to develop diabetes due to factors such as reduced physical activity, weight gain, and other age-related health issues. The increasing geriatric population in North America is thus expected to be a significant driver of demand for diabetes care devices in the coming years.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

You can see this-

North America Sleep Apnea Devices Market- https://fortunetelleroracle.com/g-blog/north-america-sleep-apnea-devices-market-global-analysis--size--share--growth--trends-and-forecast-2018---2025-1032170

North America Nurse Call Systems Market- https://www.openpr.com/news/3923912/north-america-nurse-call-systems-market-major-manufacturers

 

 

Comments

Post a Comment

Popular posts from this blog

Europe Laboratory Information Management Systems (LIMS) Market Identifying Roles and Objectives In Coming Years till 2028

Image
The laboratory information management systems (LIMS) market in Europe is expected to grow from US$ 228.16 million in 2021 to US$ 476.17 million by 2028; it is estimated to grow at a CAGR of 11.1% from 2021 to 2028. Laboratory automation is emerging as an approach to minimize human involvement in laboratory processes. The automation of routine laboratory procedures with the help of dedicated workstations and system software helps increase laboratory efficiency and enables researchers to concentrate on important tasks along with avoiding human errors. Laboratories are increasingly adopting laboratory information management systems (LIMS) to maintain stringent regulatory compliance, uplift efficiency and productivity, and drive data security and integrity. According to a study published in the Journal of Lab Automation, the error incidences in fully automated, semi-automated, and manual operations are 1–5%, 1–10%, and 10–30%, respectively. The growing use of digital workstations, auto...
Read more

North America Point-of-Care Molecular Diagnostics Market Analysis, Segments, Key Players, Drivers, Trends by Forecast 2022 to 2028

Image
  Market Introduction   North America Point-of-Care Molecular Diagnostics Market Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing. Due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes, POCT is rapidly gaining traction.Moreover, the growing demand for specific viral detection methods that consume less time for timely infection control is expected to bolster the market growth during the forecast period. North America Point-of-Care Molecular Diagnostics Market The US has the highest number of COVID-19 cases of all countries in North America. This has negatively impacted various industries, and supply and distribution chains in the region. During the pandemic, life science companies s...
Read more

North America Food Allergen Testing Market Segments, Opportunities, Regional Forecast To 2027

Image
  North America Food Allergen Testing Market Forecast to 2027 – COVID-19 Impact and Analysis – by Source (Peanut and Soy, Wheat, Milk, Egg, Tree Nuts, Seafood, and Others), Technology (PCR-Based, Immunoassay-Based / ELISA, and Other Tests/Techniques), and Food Tested (Bakery and Confectionery, Infant Food, Processed Food, Dairy Products and Alternatives, Seafood and Meat Products, and Other Foods) Market Introduction The US, Canada, and Mexico are among the developed economies in North America. A large number of domestic and international food and beverages companies have a strong foothold in the region. Moreover, rapid growth in the food and beverages industry in developed countries is expected to boost the food allergen testing market in the region in the coming years. Growing prevalence of food allergies among consumers and technological advancements in food testing procedures provide growth opportunities to the key players operating in the market. 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒...
Read more